organic compounds
7-Chloro-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidine
aLaboratoire de Chimie Organique Hétérocyclique URAC21, Pôle de Compétences Pharmacochimie, Université Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco, bInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 6005, BP 6759, 45067 Orléans Cedex 2, France, cInstitute of Nanmaterials and Nanotechnology, MASCIR, Rabat, Morocco, and dLaboratoire de Chimie du Solide Appliquée, Université Mohammed V-Agdal, Faculté des Sciences, Avenue Ibn Battouta, BP 1014, Rabat, Morocco
*Correspondence e-mail: i_bassoude@yahoo.fr
The fused pyrazole and pyrimidine rings in the title compound, C13H10ClN3, are almost coplanar, their planes being inclined to one another by 0.8 (2)°. The mean plane of the fused ring system is nearly coplanar with the phenyl ring, as indicated by the dihedral angle between their planes of 9.06 (7)°.
Related literature
For pharmacological and biochemical properties of pyrazolo[1,5-a]pyrimidine derivatives, see: Selleri et al. (2005); Almansa et al. (2001); Suzuki et al. (2001), Chen et al. (2004). For related structures, see: Senga et al. (1981).
Experimental
Crystal data
|
Data collection: APEX2 (Bruker, 2009); cell SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010).
Supporting information
https://doi.org/10.1107/S1600536813009896/rz5056sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536813009896/rz5056Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536813009896/rz5056Isup3.cml
Under argon, a mixture of 7-hydroxy-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidine (0.8 g, 3.5 mmol), phosphorus oxychloride (0.8 ml, 8.89 mmol) and triethylamine (1 mL, 7 mmol) in 1,4-dioxane (2 ml) was heated to reflux for 3 h. The reaction mixture was allowed to cool to room temperature. After evaporation of the solvent under reduced pressure and addition of a NaHCO3
at 273 K (pH = 8), the residue was extracted with CH2Cl2. The combined organic layers were dried with MgSO4, concentrated under vacuum and the residue was purified on silica gel by using a 9:1 (v/v) mixture of petroleum ether and ethyl acetate as The compound was recrystallized from a mixture of cyclohexane/CH2Cl2 (1:1 v/v) to give colourless crystals.All H atoms could be located in a difference Fourier map and treated as riding with C—H = 0.93 Å (aromatic), and C—H = 0.96 Å (methyl) and with Uiso(H) = 1.2 Ueq(aromatic) or Uiso(H) = 1.5 Ueq (methyl).
Pyrazolo[1,5-a]pyrimidines have attracted considerable interest because of their biological activity. For instance, they are known for their potent utility as selective peripheral benzodiazepine receptor ligands (Selleri et al., 2005), COX-2 selective inhibitors (Almansa et al., 2001), HMG-CoA reductase inhibitors (Suzuki et al., 2001) and CRF1 antagonists (Chen et al., 2004). Our research group targeted at the synthesis of heterocycles with a bridgehead nitrogen atom such as the title compound (Senga et al. 1981).
The
of the title compound is built up from two fused five and six-membered rings (N1/N2/C4–C6 and N1/N3/C1–C4) linked to a methyl group and to a phenyl ring (C7–C12) as shown in Fig. 1. The pyrazole and pyrimidine rings are essentially planar with maximum deviations of 0.0010 (13) Å and 0.0052 (13) Å for C6 and C1, respectively, and form a dihedral angle of 0.8 (2)°. The mean plane through the fused ring system makes a dihedral angle of 9.06 (7)° with the phenyl ring.For pharmacological and biochemical properties of pyrazolo[1,5-a]pyrimidines derivatives, see: Selleri et al. (2005); Almansa et al. (2001); Suzuki et al. (2001), Chen et al. (2004). For related structures, see: Senga et al. (1981).
Data collection: APEX2 (Bruker, 2009); cell
SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010).Fig. 1. The molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level. H atoms are represented as small circles of arbitrary radius. |
C13H10ClN3 | F(000) = 504 |
Mr = 243.69 | Dx = 1.418 Mg m−3 |
Monoclinic, P21/n | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2yn | Cell parameters from 2925 reflections |
a = 6.5993 (2) Å | θ = 3.0–28.7° |
b = 12.6166 (4) Å | µ = 0.31 mm−1 |
c = 13.8702 (5) Å | T = 296 K |
β = 100.131 (2)° | Block, colourless |
V = 1136.84 (6) Å3 | 0.41 × 0.32 × 0.21 mm |
Z = 4 |
Bruker X8 APEXII area-detector diffractometer | 2521 reflections with I > 2σ(I) |
Radiation source: fine-focus sealed tube | Rint = 0.024 |
Graphite monochromator | θmax = 28.7°, θmin = 3.0° |
φ and ω scans | h = −6→8 |
16957 measured reflections | k = −17→17 |
2925 independent reflections | l = −18→18 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.035 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.103 | H-atom parameters constrained |
S = 1.06 | w = 1/[σ2(Fo2) + (0.0523P)2 + 0.2738P] where P = (Fo2 + 2Fc2)/3 |
2925 reflections | (Δ/σ)max = 0.001 |
154 parameters | Δρmax = 0.23 e Å−3 |
0 restraints | Δρmin = −0.23 e Å−3 |
C13H10ClN3 | V = 1136.84 (6) Å3 |
Mr = 243.69 | Z = 4 |
Monoclinic, P21/n | Mo Kα radiation |
a = 6.5993 (2) Å | µ = 0.31 mm−1 |
b = 12.6166 (4) Å | T = 296 K |
c = 13.8702 (5) Å | 0.41 × 0.32 × 0.21 mm |
β = 100.131 (2)° |
Bruker X8 APEXII area-detector diffractometer | 2521 reflections with I > 2σ(I) |
16957 measured reflections | Rint = 0.024 |
2925 independent reflections |
R[F2 > 2σ(F2)] = 0.035 | 0 restraints |
wR(F2) = 0.103 | H-atom parameters constrained |
S = 1.06 | Δρmax = 0.23 e Å−3 |
2925 reflections | Δρmin = −0.23 e Å−3 |
154 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger. |
x | y | z | Uiso*/Ueq | ||
C1 | 0.07651 (19) | 0.69856 (10) | 0.25074 (9) | 0.0344 (3) | |
C2 | −0.0283 (2) | 0.72024 (10) | 0.32394 (10) | 0.0393 (3) | |
H2 | −0.1459 | 0.7622 | 0.3121 | 0.047* | |
C3 | 0.0426 (2) | 0.67836 (11) | 0.41889 (10) | 0.0420 (3) | |
C4 | 0.3143 (2) | 0.59912 (10) | 0.36620 (9) | 0.0369 (3) | |
C5 | 0.4894 (2) | 0.54075 (11) | 0.36126 (9) | 0.0398 (3) | |
H5 | 0.5708 | 0.5041 | 0.4120 | 0.048* | |
C6 | 0.51851 (19) | 0.54836 (10) | 0.26417 (9) | 0.0349 (3) | |
C7 | 0.68242 (19) | 0.49912 (10) | 0.21982 (9) | 0.0353 (3) | |
C8 | 0.8475 (2) | 0.44870 (11) | 0.27861 (11) | 0.0423 (3) | |
H8 | 0.8546 | 0.4468 | 0.3462 | 0.051* | |
C9 | 1.0010 (2) | 0.40136 (12) | 0.23699 (13) | 0.0502 (4) | |
H9 | 1.1112 | 0.3684 | 0.2768 | 0.060* | |
C10 | 0.9911 (2) | 0.40282 (13) | 0.13685 (13) | 0.0522 (4) | |
H10 | 1.0940 | 0.3706 | 0.1092 | 0.063* | |
C11 | 0.8287 (2) | 0.45210 (13) | 0.07785 (12) | 0.0521 (4) | |
H11 | 0.8215 | 0.4528 | 0.0103 | 0.063* | |
C12 | 0.6755 (2) | 0.50072 (12) | 0.11910 (11) | 0.0448 (3) | |
H12 | 0.5671 | 0.5347 | 0.0789 | 0.054* | |
C13 | −0.0778 (3) | 0.69939 (16) | 0.49944 (12) | 0.0599 (4) | |
H13A | −0.1946 | 0.7430 | 0.4748 | 0.090* | |
H13B | 0.0084 | 0.7352 | 0.5525 | 0.090* | |
H13C | −0.1239 | 0.6334 | 0.5224 | 0.090* | |
N1 | 0.24981 (16) | 0.63830 (8) | 0.27118 (7) | 0.0332 (2) | |
N2 | 0.37353 (16) | 0.60790 (9) | 0.20808 (8) | 0.0357 (2) | |
N3 | 0.20986 (19) | 0.61941 (10) | 0.43971 (8) | 0.0432 (3) | |
Cl1 | 0.00409 (5) | 0.74223 (3) | 0.13336 (2) | 0.04662 (13) |
U11 | U22 | U33 | U12 | U13 | U23 | |
C1 | 0.0348 (6) | 0.0302 (5) | 0.0367 (6) | 0.0020 (5) | 0.0021 (5) | 0.0041 (5) |
C2 | 0.0389 (7) | 0.0361 (6) | 0.0427 (7) | 0.0089 (5) | 0.0061 (5) | 0.0022 (5) |
C3 | 0.0462 (7) | 0.0413 (7) | 0.0385 (6) | 0.0091 (6) | 0.0078 (5) | −0.0005 (5) |
C4 | 0.0393 (6) | 0.0370 (6) | 0.0326 (6) | 0.0047 (5) | 0.0014 (5) | 0.0011 (5) |
C5 | 0.0401 (7) | 0.0423 (7) | 0.0351 (6) | 0.0103 (5) | 0.0012 (5) | 0.0014 (5) |
C6 | 0.0331 (6) | 0.0323 (6) | 0.0382 (6) | 0.0011 (5) | 0.0029 (5) | −0.0004 (5) |
C7 | 0.0318 (6) | 0.0319 (6) | 0.0421 (6) | −0.0016 (5) | 0.0061 (5) | −0.0006 (5) |
C8 | 0.0379 (7) | 0.0412 (7) | 0.0459 (7) | 0.0033 (5) | 0.0021 (5) | −0.0029 (5) |
C9 | 0.0359 (7) | 0.0483 (8) | 0.0647 (10) | 0.0074 (6) | 0.0044 (6) | −0.0021 (7) |
C10 | 0.0412 (8) | 0.0508 (8) | 0.0691 (10) | 0.0031 (6) | 0.0219 (7) | −0.0026 (7) |
C11 | 0.0527 (8) | 0.0576 (9) | 0.0508 (8) | 0.0019 (7) | 0.0224 (7) | 0.0033 (7) |
C12 | 0.0414 (7) | 0.0502 (8) | 0.0436 (7) | 0.0053 (6) | 0.0095 (6) | 0.0043 (6) |
C13 | 0.0659 (10) | 0.0735 (11) | 0.0433 (8) | 0.0281 (9) | 0.0176 (7) | 0.0038 (7) |
N1 | 0.0334 (5) | 0.0318 (5) | 0.0338 (5) | 0.0036 (4) | 0.0042 (4) | 0.0023 (4) |
N2 | 0.0344 (5) | 0.0360 (5) | 0.0368 (5) | 0.0026 (4) | 0.0068 (4) | 0.0024 (4) |
N3 | 0.0479 (6) | 0.0474 (6) | 0.0335 (5) | 0.0130 (5) | 0.0053 (5) | 0.0004 (5) |
Cl1 | 0.0463 (2) | 0.0521 (2) | 0.04017 (19) | 0.00949 (14) | 0.00399 (14) | 0.01307 (13) |
C1—C2 | 1.3533 (18) | C7—C8 | 1.3940 (18) |
C1—N1 | 1.3610 (16) | C8—C9 | 1.386 (2) |
C1—Cl1 | 1.7055 (13) | C8—H8 | 0.9300 |
C2—C3 | 1.4197 (19) | C9—C10 | 1.379 (2) |
C2—H2 | 0.9300 | C9—H9 | 0.9300 |
C3—N3 | 1.3201 (18) | C10—C11 | 1.377 (2) |
C3—C13 | 1.504 (2) | C10—H10 | 0.9300 |
C4—N3 | 1.3519 (17) | C11—C12 | 1.389 (2) |
C4—C5 | 1.3818 (18) | C11—H11 | 0.9300 |
C4—N1 | 1.4019 (16) | C12—H12 | 0.9300 |
C5—C6 | 1.3966 (18) | C13—H13A | 0.9600 |
C5—H5 | 0.9300 | C13—H13B | 0.9600 |
C6—N2 | 1.3503 (16) | C13—H13C | 0.9600 |
C6—C7 | 1.4727 (17) | N1—N2 | 1.3532 (15) |
C7—C12 | 1.3897 (19) | ||
C2—C1—N1 | 118.58 (11) | C10—C9—C8 | 120.34 (14) |
C2—C1—Cl1 | 123.81 (10) | C10—C9—H9 | 119.8 |
N1—C1—Cl1 | 117.61 (9) | C8—C9—H9 | 119.8 |
C1—C2—C3 | 119.48 (12) | C11—C10—C9 | 119.88 (14) |
C1—C2—H2 | 120.3 | C11—C10—H10 | 120.1 |
C3—C2—H2 | 120.3 | C9—C10—H10 | 120.1 |
N3—C3—C2 | 122.62 (12) | C10—C11—C12 | 120.10 (15) |
N3—C3—C13 | 117.87 (12) | C10—C11—H11 | 119.9 |
C2—C3—C13 | 119.50 (13) | C12—C11—H11 | 119.9 |
N3—C4—C5 | 132.85 (12) | C11—C12—C7 | 120.65 (14) |
N3—C4—N1 | 122.10 (11) | C11—C12—H12 | 119.7 |
C5—C4—N1 | 105.05 (11) | C7—C12—H12 | 119.7 |
C4—C5—C6 | 105.62 (11) | C3—C13—H13A | 109.5 |
C4—C5—H5 | 127.2 | C3—C13—H13B | 109.5 |
C6—C5—H5 | 127.2 | H13A—C13—H13B | 109.5 |
N2—C6—C5 | 112.96 (11) | C3—C13—H13C | 109.5 |
N2—C6—C7 | 119.48 (11) | H13A—C13—H13C | 109.5 |
C5—C6—C7 | 127.56 (11) | H13B—C13—H13C | 109.5 |
C12—C7—C8 | 118.62 (12) | N2—N1—C1 | 127.17 (10) |
C12—C7—C6 | 121.13 (12) | N2—N1—C4 | 112.96 (10) |
C8—C7—C6 | 120.25 (12) | C1—N1—C4 | 119.86 (11) |
C9—C8—C7 | 120.39 (14) | C6—N2—N1 | 103.41 (10) |
C9—C8—H8 | 119.8 | C3—N3—C4 | 117.35 (11) |
C7—C8—H8 | 119.8 |
Experimental details
Crystal data | |
Chemical formula | C13H10ClN3 |
Mr | 243.69 |
Crystal system, space group | Monoclinic, P21/n |
Temperature (K) | 296 |
a, b, c (Å) | 6.5993 (2), 12.6166 (4), 13.8702 (5) |
β (°) | 100.131 (2) |
V (Å3) | 1136.84 (6) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.31 |
Crystal size (mm) | 0.41 × 0.32 × 0.21 |
Data collection | |
Diffractometer | Bruker X8 APEXII area-detector |
Absorption correction | – |
No. of measured, independent and observed [I > 2σ(I)] reflections | 16957, 2925, 2521 |
Rint | 0.024 |
(sin θ/λ)max (Å−1) | 0.675 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.035, 0.103, 1.06 |
No. of reflections | 2925 |
No. of parameters | 154 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.23, −0.23 |
Computer programs: APEX2 (Bruker, 2009), SAINT (Bruker, 2009), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEP-3 for Windows (Farrugia, 2012), PLATON (Spek, 2009) and publCIF (Westrip, 2010).
Acknowledgements
The authors thank the Unit of Support for Technical and Scientific Research (UATRS and CNRST) for the X-ray measurements.
References
Almansa, C. A., Alberto, F., Cavalcanti, F. L., Gomez, L. A., Miralles, A., Merlos, M., Garcia-Rafanell, J. & Forn, J. (2001). J. Med. Chem. 44, 350–361. Web of Science CrossRef PubMed CAS Google Scholar
Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Chen, C., Wilcoxen, K. M., Huang, C. Q., Xie, Y.-F., McCarthy, J. R., Webb, T. R., Zhu, Y.-F., Saunders, J., Liu, X.-J., Chen, T.-K., Bozigian, H. & Grigoriadis, D. E. (2004). J. Med. Chem. 47, 4787–4798. Web of Science CrossRef PubMed CAS Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Selleri, S., Gratteri, P., Costagli, C., Bonaccini, C., Costanzo, A., Melani, F., Guerrini, G., Ciciani, G., Costa, B., Spinetti, F., Martini, C. & Bruni, F. (2005). Bioorg. Med. Chem. 13, 4821–4834. Web of Science CrossRef PubMed CAS Google Scholar
Senga, K., Navinson, T. & Wilson, H. R. (1981). J. Med. Chem. 24, 610–613. CrossRef CAS PubMed Web of Science Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Suzuki, M., Iwasaki, H., Fujikawa, Y., Sakashita, M., Kitahara, M. & Sakoda, R. (2001). Bioorg. Med. Chem. Lett. 11, 1285–1288. Web of Science CrossRef PubMed CAS Google Scholar
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925. Web of Science CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Pyrazolo[1,5-a]pyrimidines have attracted considerable interest because of their biological activity. For instance, they are known for their potent utility as selective peripheral benzodiazepine receptor ligands (Selleri et al., 2005), COX-2 selective inhibitors (Almansa et al., 2001), HMG-CoA reductase inhibitors (Suzuki et al., 2001) and CRF1 antagonists (Chen et al., 2004). Our research group targeted at the synthesis of heterocycles with a bridgehead nitrogen atom such as the title compound (Senga et al. 1981).
The crystal structure of the title compound is built up from two fused five and six-membered rings (N1/N2/C4–C6 and N1/N3/C1–C4) linked to a methyl group and to a phenyl ring (C7–C12) as shown in Fig. 1. The pyrazole and pyrimidine rings are essentially planar with maximum deviations of 0.0010 (13) Å and 0.0052 (13) Å for C6 and C1, respectively, and form a dihedral angle of 0.8 (2)°. The mean plane through the fused ring system makes a dihedral angle of 9.06 (7)° with the phenyl ring.